Abstract

Objective: To compare magnesium sulfate with lytic cocktail for the treatment of eclampsia. Methods: The register of trials kept by the Cochrane Pregnancy and Childbirth Group and the Cochrane Controlled Trials Register were searched for randomized trials comparing magnesium sulfate with lytic cocktail for the treatment of eclampsia. Results: Two studies were included (a total of 199 women). Magnesium sulfate was more effective than lytic cocktail at preventing further convulsions [relative risk (RR) 0.09, 95% confidence interval (C.I.)=0.03–0.24; risk difference=0.43, 95% C.I.=−0.53 to −0.34; number needed to treat=3, 95% C.I.=2–3) and was associated with less respiratory depression (RR=0.12, 95% C.I.=0.02–0.91) and fewer baby deaths (RR=0.26, 95% C.I.=0.26–0.79). There were non-significantly fewer maternal deaths associated with magnesium sulfate (RR=0.25, 95% C.I.=0.04–1.43). Conclusions: Magnesium sulfate is the anticonvulsant of choice for eclampsia. Lytic cocktail should be abandoned.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.